MARTHA ACEVEDO: Open Payments
NPI 1285297036 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 16 payments from 11 companies in 2025. Trend: 2023 $467 · 2024 $21 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Verastem, Inc. | 1 | $124 |
| Syndax Pharmaceuticals, Inc. | 4 | $96 |
| Exelixis Inc. | 2 | $65 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| PharmaEssentia USA Corporation | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: AVMAPKI FAKZYNJA CO-PACK, CABOMETYX, DARZALEX, Onivyde, BESREMI, QINLOCK, ZYNYZ, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
